The one sector of the stock market that is cheap with upside today
Karen Firestone of Aureus Asset Management breaks down the case for biopharmaceuticals. Source link
Read MoreKaren Firestone of Aureus Asset Management breaks down the case for biopharmaceuticals. Source link
Read MoreThese are some of the stocks posting the largest moves in midday trading. Source link
Read MoreHere are five key things investors need to know to start the trading day. Source link
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThe FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's
Read MoreSwiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Read MoreDemand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily
Read MoreSesame is offering compounded semaglutide — the active ingredient in Wegovy and Ozempic — to help users access obesity and
Read MoreThe late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period. Source
Read More